Vir Biotechnology, Inc.
- VIR
- NASDAQ
- Biotechnology
- Infectious Disease Biotech
- Immunology Therapeutics
$10.15
Today +1.87%Quote Oct 19, 2026, 05:45 PM UTC
−8.79%over the last month
Max drawdown −15.4%From 1-month high −15.4%3 months +7.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Vir Biotechnology
Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
367
Market value
$1.72B
Quote Oct 19
Floor
$9.93
2.1% below price
Resistance
$10.21
0.6% above price
Price vs analyst targets
12 analysts
Lowest target
$22.00Highest target
$25.00
$22.00Highest target
$25.00
- Price $10.15
- Average target $23.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 132% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VIRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free